Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lesinurad PK Interaction with Metformin and Furosemide
NCT02028689Phase 1Completed
- Sponsor
- Ardea Biosciences, Inc.
- Start
- Oct 2013
- Primary completion
- Nov 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of lesinurad in hyperuricemia and gout (2 arms), sponsored by Ardea Biosciences, Inc. Primary endpoints: PK profile of metformin from plasma at Day 5, PK profile of furosemide from plasma at Day 5 and 1 more. Started Oct 2013; status: completed.
02
Drugs
lesinurad
03
Conditions
hyperuricemiagout
Beyond the preview
Go deeper on NCT02028689.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02028689.